bioAffinity Technologies, Inc. 8-K

What Happened
bioAffinity Technologies, Inc. filed an 8-K (Item 8.01) on June 2, 2026 to announce a press release reporting that the Society for Advanced Bronchoscopy (SAB) will host a webinar focused on CyPath® Lung. The webinar will cover CyPath Lung’s expanding role in pulmonary, oncology and surgical practices for the detection and management of early-stage lung cancer. The press release is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: June 2, 2026 (Form 8-K, Item 8.01).
• Event: SAB-hosted webinar about CyPath® Lung’s clinical role in early-stage lung cancer detection and management.
• Press release: Issued by bioAffinity and included as Exhibit 99.1 to the 8-K.
• Focus areas named: pulmonary, oncology and surgical practices.

Why It Matters
This filing signals a public outreach and educational effort that could increase awareness of bioAffinity’s CyPath® Lung among clinicians and specialists. For investors, the item is notable for potential visibility and market interest but does not report financial results, revenue guidance, partnerships, or clinical outcomes. Monitor future disclosures for clinical data, commercial agreements, regulatory updates, or material financial impacts tied to CyPath Lung.